Quest Diagnostics Incorporated

DGX
Healthcare
$258.28
1.31%Overvalued

Quest Diagnostics Incorporated (DGX) is a Healthcare company that currently yields 1.31% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $143.64 and the overvaluation threshold at $199.76. Quest Diagnostics Incorporated holds a quality score of 75/100 (Good), reflecting 13 consecutive years of dividend growth with a 25% payout ratio. The 5-year dividend CAGR stands at 7.3%.

DGX Dividend Yield History — Weiss Valuation

Underval. $143.64Overval. $199.76

Distance to undervalued

Entry price is stretched

Needs 44.4% downside to reach the Weiss buy zone

Undervaluation starts near $143.64, where the annual dividend would imply roughly 2.35% yield. That is 1.04% above today's yield.

Buy-zone price

$143.64

Target yield

2.35%

Research checklist

What to clear before buying the yield

Updated Nov 21, 2026

Dividend durability

14Y

Long dividend history supports a deeper look.

Earnings payout

25%

Earnings coverage leaves room for noise.

Cash payout

43%

Free cash flow coverage supports the payment.

Dividend growth

7.3%

Recent growth adds income compounding potential.

What changed

What changed since the last update

2026-11-20 → 2026-11-21

No major change in signal, yield, price, quality, or payout since the last update.

Why Now?

Quest Diagnostics Incorporated is trading near its historical overvaluation band.

Current yield 1.3% vs historical max 2.6% (50% of maximum).

14 consecutive years without a dividend cut.

Conservative payout ratio of 25%.

What matters now

Read the signal before the headline yield

Valuation is the brake here: the yield is compressed versus its own history.

The 75/100 quality score calls for selective follow-up, not autopilot.

Start by checking whether payout coverage and business durability still support the dividend.

DGX Dividend Income Projection — DRIP Compounder

Dividend Compounder (DRIP)

$

Year 1 Income

$140

Year 10 Income

$313

Yield on Cost

3.22%

Total Income

$2,151

Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.

Track actual vs. projected

See what DGX dividends you actually received with Sharesight

Dividend income log · Yield on cost · DRIP cost basis · Tax reports

→

More research

Full price history & technical analysis

TradingView ↗

Fundamentals, valuation & analyst ratings

FinViz ↗

Moat rating & analyst fair value

Morningstar ↗

Track dividends received & tax reports

Sharesight ↗

DGX Dividend Quality Score

Quality Score

75/ 100

Good

Payout Ratio25/25
Dividend Streak20/25
Growth (CAGR 5Y)15/20
Yield vs History0/15
FCF Coverage15/15

Key Metrics

Current Price$258.28
Annual Dividend$3.38
Current Yield1.31%
Yield — Max (10Y)2.63%
Yield — Min (10Y)1.43%
Undervalued Below$143.64
Overvalued Above$199.76
Payout Ratio25.10%
CAGR Dividend 5Y7.3%
CAGR Dividend 10Y7.9%
Years No Cut14y

Invest in DGX

Check Quest Diagnostics Incorporated availability and current costs on eToro

Check eToro terms and availability →
Fractional sharesFees vary by countryCapital at risk

DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.

13
consecutive years of dividend growth